Industrial Technology Research Institute

Academia Sinica

Shu-Jiau Chiou

Cheng-Li Fang

Hui-Ping Tsai

Po-Ting Chen

Hung-Chi Chien

Yi-Cheng Cheng

Tien-Soung Tong

Ting-Shou Chen

Yung-Feng Liao

Rita P-y Chen

Chang-Jen Huang

Bo-Kai Wu

Lain-Tze Lee

Chu-Hsun Lu

I-Horng Pan

Cheng-Yu Lee

Kuo-Kuei Huang

Shu-Fang Wen

Cheng Hua Lin

Zong-Keng Kuo

Ying-Fei Tsai

I-Huang Lu

Shau-Feng Chang

Jui-Hung Yen

Shao-Chan Yin

Pei-Hsuan Wei

Rita P-Y Chen

Disclosed herein is the novel use of use of aspp. extract, which may upregulate neprilysin, induce autophagy, protect neuron from amyloidopathy or tauopathy, and/or promote neurite outgrowth, thus thespp. extract of the present disclosure may be used as a dietary supplement for the prophylaxis or treatment of amyloid related neurodegenerative diseases so as to ameliorate or alleviate symptoms associated with the amyloid related neurodegenerative diseases.

extract and uses thereof

The present disclosure provides a pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis, including: an effective amount of an extract of a plant belonging toas an effective ingredient for treating or alleviating the autoimmune disease and/or complication thereof and/or nephritis, wherein the autoimmune disease is selected from a group consisting of lupus erythematosus, psoriasis, psoriatic arthritis, ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis, Crohn's disease and ulcerative colitis (UC).

Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis

The disclosure provides a method for treating hepatitis C, including: administering an effective amount of a proanthocyanidins oligomer to a subject in need, wherein the structure of the proanthocyanidins oligomer is shown as Formula (I): and in Formula (I), N is an integer of about 1-18.

Method for treating hepatitis C

A glycosyltransferase promoter and a recombinant nucleic acid, plant cell and transgenic plant containing thereof are provided. The promoter includes a nucleotide sequence as set forth in any one of SEQ ID NOs: 1&#x2dc;7, a fragment having at least 10 contiguous bases of any one of SEQ ID NOs: 1&#x2dc;7 or a combination thereof, or a nucleotide sequence having 90% or more identity to the nucleotide sequence as set forth in any one of SEQ ID NOs: 1&#x2dc;7.

Glycosyltransferase promoter

Growing community of inventors

Hsinchu, Taiwan

Shu-Jiau Chiou